Ph.D., A.O. David A. Sinclair

David Sinclair is a tenured Professor of Genetics at Harvard Medical School. He is best known for his work on genes and small molecules that delay aging by boosting the body’s defenses and for being the first reprogram and rejuvenate tissuesin vivo.

He has published over 200 scientific papers, is a co-inventor on over 50 patent and patent applications, and has co-founded a dozen biotechnology companies in the areas of rare diseases, inflammation, vaccines, infectious disease detection, eye diseases, diabetes, fertility, cancer, and biosecurity.

His first book Lifespanbecame a New York Times best seller in 2019. He has a citation index (h-index) of 94, serves as founder and Co-Chief Editor of the scientific journal Aging, is a board member of companies, and has received 36 awards including being one of Australia's leading scientists under 45, the Australian Medical Research Medal, the NIH Director’s Pioneer award, TIME magazine’s list of the “100 most influential people in the world” and the “Top 50 people in healthcare.” In 2018, he became the equivalent of a knight as an Officer of the Order of Australia (AO) for his work in medical research, science communication, and national security.